Autoimmune Disease Diagnostic Market is US$ 18 Billion by 2025



The United States has the highest incidence of autoimmune diseases; about 50 million patients are suffering from this disease. Autoimmune Disease Diagnostic Market is US$ 18 Billion. For More Information Call Us : +1 678-302-0700

Press Release

According to the Renub Research report “Autoimmune Disease Diagnostic Market, By Disease, Regions, Tests Type, Global Forecast” the Autoimmune Disease Diagnostic Market is forecasted to exceed US$ 18 Billion by the end of the year 2025.

Increasing awareness of autoimmune diseases through research, training, aid, and advocacy services is a crucial factor that globally boosts the usage rates of autoimmune disease diagnostics. The United States has the highest incidence of autoimmune diseases; about 50 million patients are suffering from this disease.

Request a free sample copy of the report:

In the year 2017, roughly 54.4 Million people in the United States suffer from diagnosed arthritis, according to the Arthritis Foundation. According to the International Diabetes Federation (IDF)’s 2017 study, approximately 425 million adults (20-79 years) had diabetes, and this figure could grow to 629 Million worldwide by 2045.

Government organizations and NGOs are aiming to raise awareness of the socio-economic impact of autoimmunity by encouraging and fostering effective, ethical, and productive cooperation in the fields of health, public awareness, research, and patient care.

Certain factors, such as increased laboratory automation, collaborations with doctors and medical clinics, and advances in technology, drive the diagnostics demand for autoimmune disease. But, the slow diagnostic turnaround time and the high frequency of false results impede the growth of the diagnostic market for autoimmune disease.

Autoimmunity includes the failure of normal immune homeostasis as an abnormal response to its own tissue is produced by the tissue. Autoimmune diseases generally involve the presence of self-reactive T cells, inflammation, and auto-antibodies. It is challenging to diagnose possible autoimmune diseases, as not a single laboratory test alone can provide conclusive results for the condition. Therefore, there is a need for several laboratory tests, including basic studies such as acute phase reactants, flow cytometry, cytokine analysis, complete blood count, comprehensive metabolic panel, serologies, immunologic studies, and HLA typing.

Request a free Brochure copy of the report:

Although some measurements, such as the erythrocyte sedimentation rate (ESR), maybe non-specific, they are useful for evaluating disease activity. Such tests can help diagnose and treat patients with autoimmune diseases and help to provide a prognosis or indicate the extent of organ involvement or damage.

About Us

Renub Research is a Market Research and Consulting Company.

Contact Us
Renub Research
Phone: +1-678-302-0700
Email: [email protected]
Follow us on LinkedIn: